Giovanni Tamburi buys again as Roche Bobois softens into September

Giovanni Tamburi did not come in with a grand gesture. He bought twice, on September 21 and September 22, and the euro-normalised filing values were roughly EUR 11,438 and EUR 3,181. That is small money against a company with a market value of EUR 189.2 million, but the point is not size alone. Repetition matters, as does the fact that the same name has kept showing up alongside affiliated buying.

Roche Bobois closed at EUR 18.85 on September 21, so the purchases landed while the stock was already digesting a soft operating backdrop rather than trying to catch a panic low. The company had just reported half-year results on September 10, and those numbers were not pretty in the way a luxury brand would like, even if they were better than a straight-line collapse. Revenue came in at EUR 187.8 million, down 8.9% at current exchange rates and 7.3% at constant rates, with the sharpest weakness in the UK, Spain and Italy. EBITDA was EUR 31.4 million, for a 16.7% margin, and the order backlog held at EUR 122.7 million.

Europe’s furniture market is still forcing discipline

The furniture trade is not living through a clean cyclical turn. Higher borrowing costs still matter, because furniture sits close to housing, renovation and discretionary spend, and the ECB has not exactly been handing out relief. The deposit rate was raised to 2.5% in September 2026, with inflation pressure and energy costs still in the frame. That is the sort of macro that keeps a lid on big-ticket purchases, especially when consumers are already choosy.

Roche Bobois is exposed to that mood in a very direct way. The company sells high-end furniture, not staples, and its first-half print showed the strain in Europe. The UK, Spain and Italy were the weak spots in the half-year release, which matters because those are not fringe markets for a premium furniture group. When demand softens there, the company can lean on brand and mix, but it cannot pretend the cycle is not there.

The peer set makes the point more sharply. Maisons du Monde has been trading near EUR 0.22 in late September, with an approximately 88% year-to-date drop. That is a different business and a different balance-sheet story, but it tells you what the market has done to furniture names that lack a clear cushion. Roche Bobois has held a far more contained recent range around EUR 19. The market is not treating every furniture retailer the same way, and that matters when you read an insider buy. A board member buying into a name that has not been obliterated is a different signal from a rescue-style purchase in a stock that has already been cut in half, then cut again.

What the half-year numbers actually show

Roche Bobois did not report a blow-up. It reported a slowdown. That distinction matters because the stock is not being asked to price in a balance-sheet event or a sudden operational break. It is being asked to price in a business that is still profitable, still generating EBITDA, and still carrying a backlog, but doing so in a market that is not helping.

The half-year revenue of EUR 187.8 million, down 8.9% at current exchange rates, is the headline. The margin of 16.7% is the counterweight. A 16.7% EBITDA margin in a soft consumer environment is not nothing, especially when the company says second-half revenue and EBITDA should be broadly in line with the first half. That guide is cautious, and it reads like management is not trying to sell a sharp rebound. It is also a reminder that the company is not leaning on heroic assumptions to justify the current run-rate.

The backlog at EUR 122.7 million is the other number to keep in view. It does not solve the demand problem, but it gives the business some visibility. In a sector where orders can get pushed around by sentiment, financing costs and showroom traffic, backlog is one of the few hard counters to the idea that the quarter ahead will be a blank slate. Roche Bobois is not immune to the cycle. It is also not starting from zero.

Tamburi’s buying sits inside a broader cluster

InsiderTrades data puts this in a cluster, and that is the part that deserves attention. The dossier shows 12 recent declarations, four distinct insiders, and a run of buys that includes Giovanni Tamburi on September 18, September 21 and September 22, plus affiliated buying by SOCIETE PATRIMONIALE ROCHE SPR SOCIETE ANONYME on September 17, September 18 and September 21. This is not one lonely print from a director with a spare afternoon. It is a pattern.

The score attached to the latest buys is 5.1, which is modest rather than loud. That is fine. The score is not the story here. The story is that the same board-level circle has kept adding while the company is still working through a soft consumer backdrop and a cautious guide. The purchases are tiny relative to market value, under 0.01%, and that keeps the read grounded. Nobody should confuse a few thousand euros with a balance-sheet commitment. But repeated buying from the same orbit is still more informative than a single token trade.

The company is also a small-cap name, and that matters because small and mid-cap boards have historically been the band where insider information has been least priced in. That does not make every buy useful. It does make the cluster worth a closer look than a one-off print at a mega-cap where the market has already seen every angle. Roche Bobois sits in the zone where insider activity can still matter at the margin, especially when the operating picture is not clean enough to make the stock obvious on fundamentals alone.

Small-cap board buys in context

The cohort bucket here is board buys at small-cap names. Across 2,139 cases, the 90-day win rate was 47.3% and the average 90-day return was 0.69%. That is a middling historical read, not a victory lap. It says the bucket is not magic. It also says you do not need a heroic backtest to justify paying attention when a board member keeps buying into a name that is already under pressure.

The longer horizon in the same bucket is stronger, with a 365-day average return of 75.31%. That number should not be treated as a promise, and it should not be dragged into a one-stock forecast. It is a historical cohort statistic, full stop. But it does tell you why these filings remain on the desk. Over time, board-level buying in smaller names has not been a useless exercise. The trick is not to overread one print, especially when the amount is small and the business is cyclical.

If you want the strategy frame, our live out-of-sample headline for this approach is 0.81, with 26.4 and 51.5 on the same restricted EU venue universe. That framework has a short, single-regime window and does not survive search-aware deflation, so it belongs in the background, not as a promise. The screen is useful. It is not a guarantee.

Why the peer set matters more than the filing alone

Roche Bobois is not being read in isolation. The furniture and home-furnishings space is still sorting out what happens when consumers get cautious and financing costs stay elevated. That is why the comparison with Maisons du Monde matters even though the businesses are not twins. One name is trading near EUR 0.22 after a brutal year. The other is still around EUR 19 and has a backlog, a margin profile and a premium brand that give it more room to absorb the cycle.

That gap is the context for the insider buys. A board member adding to a stock that has already been marked down for sector reasons can mean several things, and the filing does not tell you which one. It can mean the insider sees value. It can mean the insider wants to keep pace with an affiliated pattern. It can mean both. What it does not mean is that the sector headwinds have vanished. The first-half numbers say the opposite.

The macro backdrop keeps the comparison honest. Higher rates still pressure housing-linked spending, and European equity volatility has not been kind to discretionary names. In that kind of tape, premium furniture can look resilient right up until the consumer blinks again. Roche Bobois has not been spared the slowdown, but it has also not been priced like a broken retailer. That middle ground is where insider buying can matter most, because the market is still deciding how much of the softness is temporary and how much is structural.

Roche Bobois at the end of September

The company now sits in a familiar but awkward place. The half-year print showed resilience, but not growth. The guide points to more of the same in the second half. The stock is not cheap enough to ignore, and not weak enough to scream distress. That is exactly the sort of setup where a repeated board-level buy can earn a second look without forcing a conclusion.

InsiderTrades data gives the latest buys a modest score, and that fits the facts. The amounts are small, the market value is not, and the purchases are part of a broader cluster rather than a lone declaration. The company’s fundamentals are decent enough to keep the door open, with a score of 68, a quality reading of 53 and no growth figure in the dossier. That is not a growth story. It is a brand and margin story trying to hold up in a weak consumer patch.

For now, the useful question is not whether Tamburi’s buying proves anything. It does not. The useful question is whether Roche Bobois can keep margins intact while Europe stays cautious and the order book does the heavy lifting. The next hard datapoint is the company’s second-half trading, and the market will be watching whether the EUR 122.7 million backlog converts into enough revenue to keep EBITDA near the first-half pace.

Filing trail and market backdrop

The filing trail is straightforward. The September 21 and September 22 buys are visible in the insider records, and the company’s September 10 half-year release gives the operating backdrop. The stock price reference comes from the September 21 close, which matters because the buys were made against a live market, not in hindsight.

The broader sector and macro read comes from the same set of public sources. The furniture peer comparison is useful because it shows how uneven the category has been, and the rate backdrop explains why even a premium name can struggle to re-rate quickly. Roche Bobois is not being judged on a vacuum. It is being judged against a consumer that is still cautious, a sector that is still soft, and a board that keeps buying anyway.

The next filing will matter if it extends the cluster. The next trading update will matter if the backlog starts to convert better than expected. Until then, the stock sits in the gap between a resilient brand and a difficult market, which is where insider buying is most interesting and least conclusive.

This is not investment advice.

Dig deeper: Roche Bobois SA's full insider filing history.

This is not investment advice.